Peter MD - Hims Hers Senior Board
| HIMS Stock | USD 25.33 1.18 4.89% |
Executive
Peter MD is Senior Board of Hims Hers Health
| Address | 2269 Chestnut Street, San Francisco, CA, United States, 94123 |
| Phone | 415 851 0195 |
| Web | https://www.forhims.com |
Hims Hers Management Efficiency
The company has return on total asset (ROA) of 0.0566 % which means that it generated a profit of $0.0566 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2635 %, meaning that it created $0.2635 on every $100 dollars invested by stockholders. Hims Hers' management efficiency ratios could be used to measure how well Hims Hers manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2024. Return On Capital Employed is likely to drop to -0.09 in 2024. At this time, Hims Hers' Net Tangible Assets are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 994.4 K in 2024, whereas Other Current Assets are likely to drop slightly above 8 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Dorria Ball | Honest Company | N/A | |
| Ayesha Zafar | Coty Inc | 67 | |
| Marc Pritchard | Procter Gamble | 60 | |
| Michael McDermott | Newell Brands | 54 | |
| Brendan Sheehey | Honest Company | 46 | |
| Valerie Haliburton | Colgate Palmolive | N/A | |
| Tom Russo | Newell Brands | N/A | |
| Graeme Carter | Coty Inc | N/A | |
| Steve Nikolopoulos | Newell Brands | N/A | |
| Rashida Lande | Estee Lauder Companies | 50 | |
| Fiona Hughes | Coty Inc | 46 | |
| Tina Romani | Kenvue Inc | N/A | |
| Olga Levinzon | Coty Inc | N/A | |
| Luani Alvarado | Kenvue Inc | 58 | |
| Heather Howlett | Kenvue Inc | 46 | |
| Amanda Seelinger | Inter Parfums | N/A | |
| Jonathan Mayle | Honest Company | 33 | |
| Mark CFA | Newell Brands | 55 | |
| Kathleen Fish | Procter Gamble | 61 | |
| Akhil Shrivastava | Estee Lauder Companies | 51 | |
| Tracy Platt | Newell Brands | 50 | |
Management Performance
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.0566 |
Hims Hers Health Leadership Team
Elected by the shareholders, the Hims Hers' board of directors comprises two types of representatives: Hims Hers inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hims. The board's role is to monitor Hims Hers' management team and ensure that shareholders' interests are well served. Hims Hers' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hims Hers' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brian OShaughnessy, Chief Officer | ||
| Peter MD, Senior Board | ||
| Jonathan CFA, VP Relations | ||
| Mike Chi, Chief Officer | ||
| Soleil JD, Chief Secretary | ||
| MD FAAD, VP Board | ||
| Yemi Okupe, Chief Officer | ||
| Khobi Brooklyn, Chief Officer | ||
| Andrew Dudum, Chairman CoFounder | ||
| Melissa Baird, Chief Officer | ||
| Amee Parekh, Senior Resources | ||
| Irene Becklund, Principal Officer | ||
| Soleil Boughton, Chief Secretary | ||
| Patrick MD, Member Officer | ||
| Scott Knoer, Chief Officer |
Hims Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hims Hers a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.0566 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 5.29 B | ||||
| Shares Outstanding | 210.1 M | ||||
| Shares Owned By Insiders | 11.39 % | ||||
| Shares Owned By Institutions | 66.10 % | ||||
| Number Of Shares Shorted | 33.84 M | ||||
| Price To Book | 12.58 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hims Stock Analysis
When running Hims Hers' price analysis, check to measure Hims Hers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hims Hers is operating at the current time. Most of Hims Hers' value examination focuses on studying past and present price action to predict the probability of Hims Hers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hims Hers' price. Additionally, you may evaluate how the addition of Hims Hers to your portfolios can decrease your overall portfolio volatility.